Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 980 of 5804
-
Peer coaches take on tobacco in opioid recovery: a new hope for quitting smoking
Disease control Not yet recruitingTobacco use is a leading cause of premature death among individuals with opioid use disorder (OUD). Nearly 75% of individuals receiving medication treatment for OUD report concurrent tobacco use disorder (MOUD-TUD), yet evidence-based TUD treatment (i.e., Food and Drug Administra…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Mayo clinic tests urine and blood for kidney cancer clues
Diagnosis Not yet recruitingThis is a correlative (lab-based) study aiming to identify protein markers in urine extracellular vesicles (EVs) that can be used to develop non-invasive molecular tests for patients with renal cell carcinoma (RCC). Aim 1 will use urine collected previously in biorepository. Aim …
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
Blue light therapy could drain abscesses faster
Disease control Not yet recruitingThe objective of this Phase 2 study is to evaluate the efficacy of methylene blue photodynamic therapy (MB-PDT) performed at the time of percutaneous abscess drainage for disinfection of deep tissue abscesses. The study includes three arms: (1) MB-PDT at a fixed drug/light dose p…
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
AI eye on the heart: new study aims to catch rare disease early
Diagnosis Not yet recruitingThe TRACE-AI Diagnostic Study will evaluate the performance of artificial intelligence (AI) models applied to electrocardiograms (AI-ECG) and echocardiograms (AI-Echo) to identify transthyretin amyloid cardiomyopathy (ATTR-CM) in adults with heart failure. Model performance will …
Sponsor: Yale University • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
Could a light cap save infant brains after cardiac arrest?
Disease control Not yet recruitingApproximately 15,200 children receive cardiopulmonary resuscitation (CPR) for in-hospital cardiac arrest (IHCA) each year in the United States. Of these, about 60% are less than one year of age. Most IHCA (85-90%) occurs in intensive care units (ICU) or other monitored settings. …
Phase: NA • Sponsor: Mitovation, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for lung cancer patients: drug combo targets tough tumors
Disease control Not yet recruitingThis prospective, single-arm, exploratory multicenter clinical study aims to investigate the safety and efficacy of Becotatug vedotin combined with Pucotenlimab (with or without radiotherapy), followed by Pucotenlimab maintenance therapy, in patients with driver gene-negative (e.…
Phase: PHASE2 • Sponsor: Anhui Provincial Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New blood test score could personalize heart failure diuretic use
Disease control Not yet recruitingBy the re-analysis, in the BIOTOOL-CHF DISCO study, of a previously enrolled cohort of patients, a Biological Congestion Score (BCS) was newly developed. The BCS integrates four congestion-related biomarkers with key clinical variables. The BIOTOOL-CHF VALID trial is designed to …
Phase: NA • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Cottonseed compound plus immunotherapy takes on tough colorectal cancer
Disease control Not yet recruitingThis is a single-center, open-label, single-arm, exploratory phase II clinical trial designed to evaluate the preliminary efficacy and safety of sintilimab in combination with oral gossypol acetate in patients with advanced pMMR/MSS colorectal cancer after failure of at least two…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New antibody cocktail targets stubborn liver disease after stem cell transplants
Disease control Not yet recruitingThe study plan aims to include patients who have been diagnosed with steroid-refractory chronic GVHD in the liver following allogeneic hematopoietic stem cell transplantation. After obtaining informed consent, the patients will receive a treatment regimen consisting of the Anti-C…
Phase: PHASE4 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a painkiller blocker boost cancer immunotherapy?
Disease control Not yet recruitingThis Phase 2, open-label, multicenter study will evaluate the safety and preliminary efficacy of axelopran in combination with pembrolizumab in patients with PD-L1 positive recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). Axelopran is a peripherally acti…
Phase: PHASE1, PHASE2 • Sponsor: Glycyx Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug XYA02 takes on tough cancers in first human trial
Disease control Not yet recruitingThis study will evaluate the safety, tolerability, and efficacy of XYA02 in participants with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: XYone Therapeutics, Inc • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Smart scans may slash radiation doses for metastatic prostate cancer
Disease control Not yet recruitingThe purpose of this study is to characterize the reduction in PSMA-avid tumor volume and metastasis-directed radiotherapy treatment intensity facilitated by PET PSMA-response adapted SABR for poly-metastatic castration sensitive prostate cancer.
Phase: EARLY_PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New program aims to give veterans with advanced cancer a stronger voice in their End-of-Life care
Symptom relief Not yet recruitingIn 2017, the VA launched the Life-Sustaining Treatment Decisions Initiative (LSTDI), a national program to promote Goals of Care communication between clinicians and patients regarding goals and preferences for care. Despite clinician training and standardized Life Sustaining Tre…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Experimental drug aims to tame rare nerve disorder
Disease control Not yet recruitingThis clinical trial aims to evaluate the safety and efficacy of obinutuzumab β in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The key research objectives are as follows:1. To assess the efficacy of obinutuzumab β for the treatment of chronic in…
Phase: PHASE1, PHASE2 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could an Immune-Boosting herb improve colorectal cancer survival?
Disease control Recruiting nowColorectal cancer (CRC) is the third most common cancer worldwide. Despite the availability of numerous standard therapies for CRC, clinical outcomes from these treatments remain unsatisfactory. The tumor microenvironment (TME) plays an important role to regulate tumor growth, pr…
Sponsor: Chou-Chen Chen • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Alcohol injection into adrenal tumors may offer surgery-free blood pressure control
Disease control Not yet recruitingThis is a prospective, single-center, single-arm study evaluating endoscopic ultrasound-guided ethanol ablation for left-sided aldosterone-producing adenoma. Eligible participants will receive the ablation procedure and be followed for safety, imaging response, biochemical remiss…
Phase: NA • Sponsor: Chongqing Medical University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Real-World study tests Once-Daily pill for ulcerative colitis in chinese adults
Disease control Not yet recruitingUlcerative colitis (UC) is a chronic inflammatory bowel disease that causes symptoms such as bloody diarrhea, abdominal pain, and frequent bowel movements. It can significantly affect patients' quality of life. Etrasimod is an oral medication taken once daily that has been shown …
Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New nerve block could replace morphine for C-Section pain
Symptom relief Not yet recruitingEffective postoperative analgesia after cesarean delivery is essential for maternal recovery, early mobilization, breastfeeding, and maternal-infant bonding. Although intrathecal morphine (ITM) is considered the gold standard for post-cesarean analgesia, its use is associated wit…
Phase: NA • Sponsor: Ondokuz Mayıs University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Virtual reality nature escape may calm fear of childbirth in High-Risk pregnancies
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate the effect of a virtual reality (VR) video intervention on fear of childbirth and anxiety among hospitalized high-risk pregnant women receiving bed rest. High-risk pregnancy and prolonged hospitalization may increase psychological…
Phase: NA • Sponsor: Sümeyye BAL • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Marathon runners and heart patients put a new troponin test to the ultimate challenge
Diagnosis Recruiting nowTroponin elevation can, among others, be due to myocardial infarction, acute inflammation or structural heart disease. Formation of macrocomplexes against troponin is an underestimated cause for persistent troponin elevation. Polyethlylene glycol precipitation (PEG) can different…
Phase: NA • Sponsor: Technical University of Munich • Aim: Diagnosis
Last updated Jul 26, 2026 00:00 UTC